BeiGene ends pact with Shoreline, its `entry into cell therapy`
26 Feb 2024 //
ENDPTS
Shoreline To Participate At The 2023 Wedbush Pacgrow Healthcare Conference
03 Aug 2023 //
PR NEWSWIRE
Shoreline Biosciences Names Mauro Avanzi Chief Medical Officer
21 Feb 2023 //
CONTRACT PHARMA
Editas, in next restructuring step, to sell cell therapy work to Shoreline
20 Jan 2023 //
BIOPHARMADIVE
Shoreline Biosciences To Present Two Posters On Ink Cell Platform at NK2022
10 May 2022 //
PRNEWSWIRE
Dendreon and Shoreline Enter CMC Agreement
08 Nov 2021 //
CONTRACTPHARMA